Felix Feng discusses the implications of identifying molecular biomarkers of response to apalutamide in patients with nonmetastatic castration-resistant prostate cancer (5:18).
17-02-2021 | ASCO GU 2021 | Conference coverage | Video
17-02-2021 | ASCO GU 2021 | Conference coverage | Video
Felix Feng discusses the implications of identifying molecular biomarkers of response to apalutamide in patients with nonmetastatic castration-resistant prostate cancer (5:18).